Product Origin Matters When Selling To U.S. Govt., Settlement Shows
This article was originally published in PharmAsia News
Executive Summary
The orthopedic firm Smith & Nephew recently settled what may be the first suit targeting a medical device company for violations of the U.S. Trade Agreements Act, which requires products sold to the U.S. government to be made in the U.S. or in countries that have signed a trade agreement with the U.S.
You may also be interested in...
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?
Scott Gottlieb Calls It Quits After An Active Tenure At US FDA
The commissioner says he will step down next month, leaving a legacy of active policy development, but also a lot of initiatives and pilot projects that are in the middle of being implemented.